Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects

• Główni autorzy: Feifei Sun (Autor), Yanping Liu (Autor), Ting Li (Autor), Pingping Lin (Autor), Xin Jiang (Autor), Xin Li (Autor), Chenjing Wang (Autor), Xiaomeng Gao (Autor), Yaping Ma (Autor), Yao Fu (Autor), Yu Cao (Autor)
• Format: Książka
• Wydane: BMC, 2023-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background Ezetimibe is a new class of antihyperlipidemic agent indicated for the prevention of atherosclerosis disease and for the treatment of hypercholesterolemia. Information on the pharmacokinetic profiles of ezetimibe tablet in healthy Chinese volunteers are lacking, and regulatory re...